California 2023-2024 Regular Session

California Assembly Bill AB1841

Introduced
1/16/24  
Introduced
1/16/24  
Refer
1/29/24  
Refer
1/29/24  
Report Pass
3/6/24  
Report Pass
3/6/24  
Refer
3/7/24  
Report Pass
3/13/24  
Refer
3/13/24  
Refer
3/13/24  
Report Pass
4/10/24  
Report Pass
4/10/24  
Engrossed
4/18/24  
Engrossed
4/18/24  
Refer
4/18/24  
Refer
4/18/24  
Refer
5/1/24  
Report Pass
5/20/24  
Report Pass
5/20/24  
Refer
5/20/24  
Refer
5/20/24  
Report Pass
5/29/24  
Report Pass
5/29/24  
Refer
5/29/24  
Refer
5/29/24  
Report Pass
6/10/24  
Report Pass
6/10/24  
Refer
6/10/24  
Report Pass
6/20/24  
Report Pass
6/20/24  
Refer
6/20/24  
Refer
6/20/24  
Refer
8/5/24  
Refer
8/5/24  
Report Pass
8/15/24  
Enrolled
8/27/24  
Enrolled
8/27/24  
Chaptered
9/29/24  
Chaptered
9/29/24  
Passed
9/29/24  

Caption

Student safety: opioid overdose reversal medication: student housing facilities.

Impact

The bill mandates that each campus health center distribute doses of federally approved opioid overdose reversal medication to affiliated student housing facilities, including fraternities and sororities. Additionally, it requires at least two doses of this medication to be maintained in accessible locations within these housing facilities. The bill also defines specific responsibilities for residential advisors and house managers, who must complete opioid overdose prevention training and inform students about the availability and use of the reversal tool. This new requirement constitutes a state-mandated local program, potentially impacting operational protocols at campuses across California.

Summary

Assembly Bill 1841, introduced by Assemblymember Weber, focuses on enhancing student safety at postsecondary educational institutions in California regarding opioid overdose prevention. The bill amends the Education Code to require community colleges and the California State University system to provide mandatory training and informational sessions to students about opioid overdose and the administration of overdose reversal medications such as Naloxone. This legislative measure is aimed at combating the rising issues of opioid misuse and overdose, particularly in campus settings where such occurrences can be life-threatening.

Sentiment

The sentiment surrounding AB 1841 appears to be largely positive among supporters who see it as a necessary step towards safeguarding student health and wellness on campuses. Educational institutions have expressed a commitment to ensuring student safety, particularly in the face of rising opioid-related incidents. However, some concerns may arise regarding the implications of introducing such mandates on faculty workloads and the need for sufficient resources to implement these programs effectively.

Contention

One notable point of contention may revolve around the provisions that prohibit disciplinary actions against students for drug possession or usage if they are involved in administering an overdose reversal medication in a crisis. Critics might argue about how this policy addresses the broader issues of drug policy on campus, balancing student safety against ensuring compliance with existing regulations. Furthermore, some stakeholders may question the funding and resources needed to support the training and medication distribution outlined in the bill.

Companion Bills

No companion bills found.

Similar Bills

CA AB461

Student safety: fentanyl test strips.

CO HB1326

Fentanyl Accountability And Prevention

CA SB19

Fentanyl Misuse and Overdose Prevention Task Force.

CA SB997

Pupil health: opioid antagonists and fentanyl test strips.